Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 10,184 | 2,379 | 5,534 | 3,369 | 4,333 |
| Gross Profit | 10,184 | 2,379 | 5,534 | 3,369 | 4,333 |
| Operating Expenses | 20,441 | 18,354 | 16,199 | 16,559 | 18,238 |
| Operating Income | -10,257 | -15,975 | -10,665 | -13,190 | -13,905 |
| Other Income | 138 | 311 | 248 | 325 | 100 |
| Pre-tax Income | -10,119 | -15,664 | -10,417 | -12,865 | -13,805 |
| Income Tax | 29 | N/A | 1 | N/A | 20 |
| Net Income Continuous | -10,148 | -15,664 | -10,418 | -12,865 | -13,826 |
| Net Income | $-10,148 | $-15,664 | $-10,418 | $-12,865 | $-13,826 |
| EPS Basic Total Ops | -0.09 | -0.15 | -0.09 | -0.12 | -0.14 |
| EPS Basic Continuous Ops | -0.09 | -0.15 | -0.10 | -0.12 | -0.13 |
| EPS Diluted Total Ops | -0.09 | -0.15 | -0.09 | -0.12 | -0.14 |
| EPS Diluted Continuous Ops | -0.09 | -0.15 | -0.10 | -0.12 | -0.13 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.15 | -0.09 | -0.12 | -0.14 |
| EBITDA(a) | $-9,441 | $-15,163 | $-9,973 | $-12,360 | $-13,083 |